User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 81 - 225 of 374 results.

Pages

    • Speech
    Outcome of Multimodality Treatment of High-risk Localized Prostate Cancer (ct3-4 Or Psa >= 20 Ng/ml Or Biopsy Gleason Score >= 8) With Radical Prostatectomy As Initial Step: a Multi-institutional Outcome Study of 1413 Patients
    Joniau, Steven[UCL] Tombal, Bertrand[UCL] Spahn, M. Gontero, P. Bangma, C. Walz, J. Hsu, C. Y.[UCL] Van Der Eeckt, K.[UCL] Marchioro, G. Bader, P. Frohneberg, D. Graefen, M. Huland, H. Schroder, F. Tizzani, A. Van Cangh, Paul[UCL] Van Poppel, H.[UCL] (2009) —
    • Speech
    Determining the dose of degarelix for effective therapy of prostate cancer patients as investigated by the degarelix study groups
    Tombal, Bertrand[UCL] Iversen, Peter Van Poppel, Hendrik Tammela, Teuvo L. de la Rosette, Jean J. Johansson, Jan-Erik Persson, Bo-Eric Jensen, Jens-Kristian Olesen, Tine Kold (2006) 30th Congress of the European-Society-for-Medical-Oncology — Istanbul (Turkey)
    • Speech
    Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer
    Van Cangh, Paul[UCL] De Nayer, Philippe[UCL] Sauvage, P. Tombal, Bertrand[UCL] Elsen, M. Lorge, Francis Opsomer, Reinier-Jacques Wese, François-Xavier[UCL] (1996) 1st International Consultation on Prostate Cancer — Monte Carlo (Monaco)
    • Speech
    What is new in hormone therapy for prostate cancer in 2007?
    Tombal, Bertrand[UCL] (2008) Oncoforum Urology Meeting — Brussels (Belgium)
    • Speech
    The importance of testosterone control in prostate cancer
    Tombal, Bertrand[UCL] (2007) Satellite Symposium on Management of Prostate Cancer held at the 22nd EAU Annual Meeting — Berlin (Germany)
    • Speech
    PREDICTING PROSTATE CANCER-SPECIFIC OUTCOME AMONG MEN WITH PSA >= 20 ng/ml AND MULTIPLE UNFAVOURABLE RISK FACTORS: A MULTI-INSTITUTIONAL OUTCOME STUDY OF 712 PATIENTS
    Spahn, M. Tombal, Bertrand[UCL] Gontero, P. Joniau, Steven[UCL] Marchioro, G. Fieuws, Steffen[UCL] Kneitz, B. Hsu, C. Y.[UCL] Van Der Eeckt, K.[UCL] Bader, P. Frohneberg, D. Frea, B. Terrone, C. Tizzani, A. Van Poppel, H.[UCL] (2010) —
    • Speech
    Outcome of Multimodality Treatment of Clinically Locally Advanced Prostate Cancer With Radical Prostatectomy As Initial Step: a Multi-institutional Outcome Study of 895 Patients
    Gontero, P. Tombal, Bertrand[UCL] Spahn, M. Joniau, Steven[UCL] Bangma, C. Walz, J. Hsu, C. Y.[UCL] Van Der Eeckt, K.[UCL] Marchioro, G. Bader, P. Frohneberg, D. Graefen, M. Huland, H. Schroder, F. Tizzani, A. Van Cangh, Paul[UCL] Van Poppel, H.[UCL] (2009) —
    • Speech
    Free to total prostate-specific antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/ml total PSA
    Van Cangh, Paul[UCL] De Nayer, Philippe[UCL] DeVischer, L Sauvage, P. Tombal, Bertrand[UCL] Lorge, Francis Wese, François-Xavier[UCL] Opsomer, Reinier-Jacques (1996) 91st Annual Meeting of the American-Urological-Association — Orloando (Fl)
    • Speech
    Impact of total psa (TPSA) who calibration on decision points in screening for prostate cancer (PCA)
    Fille, C. Philippe, Marianne[UCL] Tombal, Bertrand[UCL] (2008) —
    • Speech
    Outcome of multimodality treatment of high-risk localized prostate cancer (cT3-4 OR PSA >= 20 ng/ml OR biopsy Gleason score >= 8) with radical prostatectomy as initial step: a multi-institutional outcome study of 1413 patients
    Spahn, M. Tombal, Bertrand[UCL] Gontero, P. Bangma, C. Walz, J. Hsu, C. Y.[UCL] Van der Eeckt, Katie[UCL] Marchioro, G. Bader, P. Frohneberg, D. Graefen, M. Huland, H. Schroder, F. Tizzani, A. Van Cangh, Paul[UCL] van Poppel, H.[UCL] Joniau, Steven[UCL] (2010) —
    • Speech
    Degarelix Vs. Leuprolide Treatment in Patients With Advanced Prostate Cancer: Psa Failures During a Randomised, Phase Iii Trial (cs21)
    Tombal, Bertrand[UCL] Miller, K. Boccon-Gibod, L. Schroder, F. Jensen, J. K. Olesen, T. K. Persson, B-E (2009) —
    • Speech
    Advances in the Therapy of Prostate Cancer-Induced Bone Disease: Current Insights and Future Perspectives on the RANK/RANKL Pathways
    Miller, Kurt Tombal, Bertrand[UCL] Stenzl, Arnulf (2009) 2nd World Congress on Controversies in Urology — Lisbon (Portugal)
    • Speech
    Optimal testosterone control and Eligard (R)
    Tombal, Bertrand[UCL] Berges, Richard (2007) Closed Expert Meeting on New Horizons in Urology — Marbella (Spain)
    • Speech
    A multi-institutional analysis comparing adjuvant and salvage postoperative radiation therapy for prostate cancer patients with undetectable PSA and high-risk features in the prostatectomy specimen
    Budiharto, T. Tombal, Bertrand[UCL] Scalliet, Pierre[UCL] Perneel, C. Haustermans, Karin[UCL] Junius, S. Vekemans, K. Joniau, Steven[UCL] Van Poppel, H. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin (Germany)
    • Speech
    The Importance of Positive Section Margins in Patients With High Risk Prostate Cancer Treated With Radical Prostatectomy
    Joniau, Steven[UCL] Tombal, Bertrand[UCL] Gontero, P. Spahn, M. Walz, J. Bangma, C. Hsu, C. Y. Marchioro, G. Van Der Eeckt, K. Bader, P. Frohneberg, D. Graefen, M. Huland, H. Schroder, F. Tizzani, A. Van Cangh, Paul[UCL] Van Poppel, H. (2009) —
    • Speech
    The Role of Adjuvant Treatment Strategies After Surgery for High-risk Localized Prostate Cancer
    Spahn, M. Tombal, Bertrand[UCL] Joniau, Steven[UCL] Gontero, P. Walz, J. Hsu, C. Y. Marchioro, G. Van Der Eeckt, K. Bader, P. Bangma, C. Frohneberg, D. Graefen, M. Huland, H. Schroder, F. Tizzani, A. Van Cangh, Paul[UCL] Van Poppel, H. (2009) —
    • Speech
    Value of 18F-methyl-Choline PET to monitor prostate cancer response to docetaxel treatment
    Lhommel, Renaud[UCL] Bohn, P. Levêque, Philippe[UCL] Labar, Daniel[UCL] Bol, Anne[UCL] Bausart, R.[UCL] Lonneux, Max[UCL] Tombal, Bertrand[UCL] (2007) 20th Annual Congress of the European-Association-of-Nuclear-Medicine — Copenhagen (Denmark)
    • Journal article
    Innovations dans le traitement hormonal du cancer de la prostate localement avancé et/ou métastatique [Innovations in hormonal treatment for locally advanced and/or metastatic prostate cancer]
    Audenet, F. Rouprêt, M. Tombal, Bertrand[UCL] (2011) Progrès en Urologie — Vol. 21, no. Suppl 3, p. S96-S101 (2011)
    • Journal article
    A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer
    Crawford, E. David Tombal, Bertrand[UCL] Miller, Kurt Boccon-Gibod, Laurent Schröder, Fritz Shore, Neal Moul, Judd W. Jensen, Jens-Kristian Olesen, Tine Kold Persson, Bo-Eric (2011) The Journal of Urology — Vol. 186, no. 3, p. 889-897 (2011)
    • BookChapter
    Genitourinary Cancer
    Tombal, Bertrand[UCL] (2012) Side Effects of Medical Cancer Therapy: Prevention and Treatment — [ISBN : 978-0-85729-786-0]
    • Journal article
    Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting
    Dickinson, Louise Ahmed, Hashim U. Allen, Clare Barentsz, Jelle O. Carey, Brendan Futterer, Jurgen J. Heijmink, Stijn W. Hoskin, Peter J. Kirkham, Alex Padhani, Anwar R. Persad, Raj Puech, Philippe Punwani, Shonit Sohaib, Aslam S. Tombal, Bertrand[UCL] Villers, Arnauld van der Meulen, Jan Emberton, Mark (2011) European Urology — Vol. 59, no. 4, p. 477-494 (2011)
    • Journal article
    The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature
    Sonpavde, Guru Attard, Gerhardt Bellmunt, Joaquim Mason, Malcolm D. Malavaud, Bernard Tombal, Bertrand[UCL] Sternberg, Cora N. (2011) European Urology — Vol. 60, no. 2, p. 270-278 (2011)
    • Journal article
    The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysis.
    Schubert, Maria Joniau, Steven Gontero, Paolo Kneitz, Susanne Scholz, Claus-Jürgen Kneitz, Burkhard Briganti, Alberto Karnes, R Jeffrey Tombal, Bertrand[UCL] Walz, Jochen Hsu, Chao-Yu Marchioro, Giansilvio Bader, Pia Bangma, Chris Frohneberg, Detlef Graefen, Markus Schröder, Fritz Van Cangh, Paul[UCL] van Poppel, Hein Spahn, Martin (2012) Advances in Urology — Vol. 2012, p. 612707 (2012)
    • Journal article
    Cardiovascular risk during hormonal treatment in patients with prostate cancer
    Van Poppel, Hein Tombal, Bertrand[UCL] (2011) Cancer Management and Research — Vol. 3, p. 49-55 (2011)
    • Journal article
    Maximizing outcomes in genitourinary cancers across the treatment continuum
    Fitzpatrick, John M. Bellmunt, Joaquim Dreicer, Robert Fleshner, Neil E. Logothetis, Christopher J. Moul, Judd W. Tombal, Bertrand[UCL] Zlotta, Alexandre (2011) BJU International — Vol. 107, no. Suppl 2, p. 1-12 (2011)

Pages